These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28515494)

  • 21. Comparative analysis of functional assays for characterization of agonist ligands at G protein-coupled receptors.
    Niedernberg A; Tunaru S; Blaukat A; Harris B; Kostenis E
    J Biomol Screen; 2003 Oct; 8(5):500-10. PubMed ID: 14567777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphopenia induced by a novel selective S1P(1) antagonist structurally unrelated to S1P.
    Fujii Y; Ohtake H; Ono N; Hara T; Sakurai T; Takahashi S; Takayama T; Fukasawa Y; Shiozawa F; Tsukahara N; Hirayama T; Igarashi Y; Goitsuka R
    Biochim Biophys Acta; 2012 Apr; 1821(4):600-6. PubMed ID: 22265714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence.
    Rosen H; Stevens RC; Hanson M; Roberts E; Oldstone MB
    Annu Rev Biochem; 2013; 82():637-62. PubMed ID: 23527695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease.
    Pyne S; Lee SC; Long J; Pyne NJ
    Cell Signal; 2009 Jan; 21(1):14-21. PubMed ID: 18768158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis.
    Parham KA; Zebol JR; Tooley KL; Sun WY; Moldenhauer LM; Cockshell MP; Gliddon BL; Moretti PA; Tigyi G; Pitson SM; Bonder CS
    FASEB J; 2015 Sep; 29(9):3638-53. PubMed ID: 25985799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingosine-1-phosphate metabolism: A structural perspective.
    Pulkoski-Gross MJ; Donaldson JC; Obeid LM
    Crit Rev Biochem Mol Biol; 2015; 50(4):298-313. PubMed ID: 25923252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel selective allosteric and bitopic ligands for the S1P(3) receptor.
    Jo E; Bhhatarai B; Repetto E; Guerrero M; Riley S; Brown SJ; Kohno Y; Roberts E; Schürer SC; Rosen H
    ACS Chem Biol; 2012 Dec; 7(12):1975-83. PubMed ID: 22971058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural biology of the S1P1 receptor.
    Hanson MA; Peach R
    Curr Top Microbiol Immunol; 2014; 378():23-53. PubMed ID: 24728592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
    Kohno T; Igarashi Y
    Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase.
    Takashima S; Sugimoto N; Takuwa N; Okamoto Y; Yoshioka K; Takamura M; Takata S; Kaneko S; Takuwa Y
    Cardiovasc Res; 2008 Sep; 79(4):689-97. PubMed ID: 18480127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay.
    Yin H; Chu A; Li W; Wang B; Shelton F; Otero F; Nguyen DG; Caldwell JS; Chen YA
    J Biol Chem; 2009 May; 284(18):12328-38. PubMed ID: 19286662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGR5 activation suppressed S1P/S1P2 signaling and resisted high glucose-induced fibrosis in glomerular mesangial cells.
    Yang Z; Xiong F; Wang Y; Gong W; Huang J; Chen C; Liu P; Huang H
    Pharmacol Res; 2016 Sep; 111():226-236. PubMed ID: 27317945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A; Pfeilschifter J
    Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
    Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
    J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist-dependent effects of mutations in the sphingosine-1-phosphate type 1 receptor.
    van Loenen PB; de Graaf C; Verzijl D; Leurs R; Rognan D; Peters SL; Alewijnse AE
    Eur J Pharmacol; 2011 Sep; 667(1-3):105-12. PubMed ID: 21663738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro metabolism of sphingosine-1-phosphate: identification; inhibition and pharmacological implications.
    Bradley ME; McGuinness N; Williams G; Charlton SJ; Dowling MR
    Eur J Pharmacol; 2011 Dec; 672(1-3):56-61. PubMed ID: 21970805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
    Clemens JJ; Davis MD; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a rapid, non-radioactive method to quantify internalisation of G-protein coupled receptors.
    Jongsma M; Florczyk UM; Hendriks-Balk MC; Michel MC; Peters SL; Alewijnse AE
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jul; 375(5):329-36. PubMed ID: 17497135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors.
    Emtage AL; Mistry SN; Fischer PM; Kellam B; Laughton CA
    J Biomol Struct Dyn; 2017 Sep; 35(12):2604-2619. PubMed ID: 27532213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A practical process for the preparation of [(32)P]S1P and binding assay for S1P receptor ligands.
    Rosenberg AJ; Liu H; Tu Z
    Appl Radiat Isot; 2015 Aug; 102():5-9. PubMed ID: 25931137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.